Aigen Investment Management LP Has $301,000 Stock Holdings in The Clorox Company (NYSE:CLX)

Aigen Investment Management LP trimmed its holdings in shares of The Clorox Company (NYSE:CLX) by 39.6% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,849 shares of the company’s stock after selling 1,214 shares during the period. Aigen Investment Management LP’s holdings in Clorox were worth $301,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also recently bought and sold shares of the business. First Foundation Advisors purchased a new stake in shares of Clorox in the first quarter worth approximately $31,000. Innealta Capital LLC acquired a new position in Clorox in the 2nd quarter valued at approximately $30,000. Trifecta Capital Advisors LLC lifted its position in Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares in the last quarter. Quarry LP boosted its stake in shares of Clorox by 99.1% during the 2nd quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after buying an additional 114 shares during the period. Finally, Family Firm Inc. purchased a new position in shares of Clorox during the 2nd quarter valued at $31,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently issued reports on the company. Evercore ISI reduced their price objective on Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a research report on Monday, October 14th. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and boosted their price target for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Barclays boosted their target price on shares of Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a research report on Friday, November 1st. JPMorgan Chase & Co. upped their price objective on shares of Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a report on Friday, October 11th. Finally, Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and raised their target price for the company from $174.00 to $187.00 in a report on Tuesday, October 1st. Five investment analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $155.00.

Clorox Stock Performance

NYSE CLX opened at $167.69 on Friday. The company’s fifty day moving average is $162.39 and its two-hundred day moving average is $147.34. The firm has a market capitalization of $20.76 billion, a price-to-earnings ratio of 58.43, a P/E/G ratio of 3.06 and a beta of 0.41. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $169.09.

Clorox (NYSE:CLX) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating the consensus estimate of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The company’s revenue for the quarter was up 27.0% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.49 EPS. Equities research analysts forecast that The Clorox Company will post 6.85 EPS for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were issued a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.91%. The ex-dividend date of this dividend was Wednesday, October 23rd. Clorox’s payout ratio is 170.04%.

Insider Activity

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This represents a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.57% of the stock is owned by company insiders.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.